| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |